Price
$0.60
Decreased by -21.90%
Dollar volume (20D)
220.70 K
ADR%
7.82
Earnings report date
Mar 5, 2025
Shares float
91.94 M
Shares short
8.57 M [9.33%]
Shares outstanding
150.78 M
Market cap
115.83 M
Beta
-0.07
Price/earnings
N/A
20D range
0.57 0.81
50D range
0.57 1.04
200D range
0.57 2.10

OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States.

The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device.

It has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail.

The company was founded in 2000 and is headquartered in Yardley, Pennsylvania.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Aug 8, 24 -0.05
Decreased by -350.00%
-0.08
Increased by +37.50%
May 14, 24 -0.12
Increased by +29.41%
-0.11
Decreased by -9.09%
Mar 7, 24 -0.09
Increased by +47.06%
-0.09
Nov 9, 23 -0.08
Increased by +55.56%
-0.09
Increased by +11.11%
Aug 10, 23 0.02
Increased by +108.70%
-0.11
Increased by +118.18%
May 11, 23 -0.17
Increased by +45.16%
-0.14
Decreased by -21.43%
Mar 7, 23 -0.17
Increased by +26.09%
-0.17
Nov 10, 22 -0.18
Increased by +43.75%
-0.18
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Jun 30, 24 20.49 M
Increased by +5.33%
-7.58 M
Decreased by -388.69%
Decreased by -37.00%
Decreased by -374.09%
Mar 31, 24 14.88 M
Increased by +25.61%
-14.07 M
Increased by +24.59%
Decreased by -94.54%
Increased by +39.97%
Dec 31, 23 19.86 M
Decreased by -4.75%
-9.97 M
Increased by +42.49%
Decreased by -50.17%
Increased by +39.62%
Sep 30, 23 19.82 M
Decreased by -1.27%
-9.29 M
Increased by +37.83%
Decreased by -46.88%
Increased by +37.03%
Jun 30, 23 19.45 M
Decreased by -5.48%
2.63 M
Increased by +113.54%
Increased by +13.50%
Increased by +114.32%
Mar 31, 23 11.85 M
Decreased by -19.74%
-18.65 M
Increased by +26.36%
Decreased by -157.47%
Increased by +8.25%
Dec 31, 22 20.86 M
Decreased by -7.34%
-17.33 M
Decreased by -10.94%
Decreased by -83.10%
Decreased by -19.73%
Sep 30, 22 20.08 M
Decreased by -8.01%
-14.95 M
Increased by +12.67%
Decreased by -74.45%
Increased by +5.06%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY